Overview
Management Team
Board of Directors
Clinical Advisory Board
Picoplatin Overview
Picoplatin Value
Proposition
Colorectal Cancer
Prostate Cancer
Ovarian Cancer
Small Cell Lung Cancer
Overview
Annual Repoort
SEC Filings
Stock Information
News Releases
Event Calendar
Presentations and
Publications
Shareholder Services
Corporate Governance
Locations
Corporate
Communications &
Investor Relations
Business Development
P
oniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative oncology products to impact the lives of people with cancer.
NEWS
Poniard Pharmaceuticals Reports Second Quarter 2010 Financial Results
- 08/09/2010
Poniard Pharmaceuticals to Host Second Quarter 2010 Financial Results Conference Call
- 08/02/2010
Poniard Announces Final Data from Phase 3 SPEAR Trial of Picoplatin in Small Cell Lung Cancer
- 06/05/2010
EVENTS & PRESENTATIONS
Q2 2010 Poniard Pharmaceuticals Earnings Conference Call
Monday, August 9, 2010
4:30 p.m. ET
About Poniard
|
Picoplatin Overview & Market Opportunities
|
Investors
|
Contact Us
© 2010 Poniard Pharmaceuticals.
Corporate Governance
|
Site Users Guide
